The S&P 500 Index rose to 7,650 points on Monday as top technology stocks continued rising. It has jumped by 1.95% from its lowest level last week.
Recursion Pharmaceuticals NASDAQ: RXRX outlined its strategy, clinical pipeline and partnership progress at Morgan Stanley's Global Healthcare Conference, with CEO and President Najat Khan emphasizing the company's shift toward an end-to-end, AI-enabled drug discovery and development platform.
IDEXX Laboratories NASDAQ: IDXX executives reiterated the company's long-term growth framework at the Morgan Stanley Global Healthcare Conference, citing demand for veterinary diagnostics, product innovation, commercial investments and recurring-revenue economics as key drivers.
| Capital Markets Industry | Financials Sector | Vincent Amabile Jr. CEO | OTC PINK Exchange | 61735R203 CUSIP |
| US Country | 5 Employees | - Last Dividend | 11 Jun 2020 Last Split | 19 Feb 2002 IPO Date |
Morgan Group Holding Co. operates through its subsidiary G.research, LLC, providing a range of financial services primarily focused on institutional research and securities brokerage within the United States. Founded in 2001 and headquartered in Rye, New York, the company has positioned itself as a key player in the financial industry by serving a diverse clientele. Its offerings cater to institutional clients, asset managers, mutual funds, as well as addressing the needs of private wealth management clients and retail customers. The company’s commitment to delivering in-depth institutional research alongside its brokerage services has established it as a reliable firm in the securities market.